# The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia

> **NCT01091571** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Endotoxemia

## Interventions

- **DRUG:** Dipyridamole
- **DRUG:** Placebo
- **OTHER:** LPS

## Key facts

- **NCT ID:** NCT01091571
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01091571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01091571, "The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01091571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*